Abstract
idiopathic pulmonary fibrosis (IPF) is an insidious and progressive disease that has devastating consequences on affected individuals and their families ([4][1], [22][2]). Approximately 50,000 individuals in the United States have this disease and most will develop respiratory failure within 3 to 5
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Physiology-Lung Cellular and Molecular Physiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
